Redini F, Lafuma C, Hornebeck W, Choay J, Robert L
Laboratoire de Biochimie du Tissu Conjonctif, CNRS UA 1174, Faculté de médecine, Créteil, France.
Biochem Pharmacol. 1988 Nov 15;37(22):4257-61. doi: 10.1016/0006-2952(88)90604-1.
The in vitro and in vivo effects of heparin fragments (CY 216; CY 222) towards elastase(s) and elastase inhibitor (alpha 1 Pi) were studied. Heparin as well as its lower Mr fragments were shown to inhibit rat leucocyte elastase. The interaction between this enzyme and heparins appears to occur via electrostatic forces. Porcine pancreatic elastase is unaffected by heparin(s) but CY 216 and CY 222 could partly abolish the hydrolytic activity of hamster serum on Suc-Ala-Ala-Ala-N-PhNO2. N desulphated N acetylated CY 142 and CY 143 had no effect. CY 216 and CY 222 decreased in vitro the inhibitory potential of alpha 1 proteinase inhibitor (alpha 1 Pi) as well as the elastase inhibitory capacity of hamster serum. Maximum effect (30% decrease) was observed at ng concentrations of CY 216 and CY 222. Their N desulphated N acetylated counterparts (CY 142 and CY 143), but not heparin, exhibited similar effects. CY 216 and CY 222 were administered daily subcutaneously to hamsters and blood was collected 1, 2, 4, 7 and 24 hr after treatment for determining both serum elastase activity (E.A.) and serum elastase inhibitory capacity (E.I.C.). E.A. levels dropped by 30% 2 hr after CY 216 or CY 222 injection but returned to original values 4-7 hr later. This effect is independent of the duration of the treatment. Hamster serum E.I.C. was significantly increased (greater than 30%) after 3-4 weeks of treatment with CY 216 and CY 222. These findings point towards the potential use of these compounds in elastase-related diseases such as emphysema.
研究了肝素片段(CY 216;CY 222)对弹性蛋白酶和弹性蛋白酶抑制剂(α1抗胰蛋白酶)的体外和体内作用。肝素及其低分子量片段均显示能抑制大鼠白细胞弹性蛋白酶。该酶与肝素之间的相互作用似乎是通过静电力发生的。猪胰弹性蛋白酶不受肝素影响,但CY 216和CY 222可部分消除仓鼠血清对Suc-Ala-Ala-Ala-N-PhNO2的水解活性。N-去硫酸化N-乙酰化的CY 142和CY 143无作用。CY 216和CY 222在体外降低了α1蛋白酶抑制剂(α1抗胰蛋白酶)的抑制潜能以及仓鼠血清的弹性蛋白酶抑制能力。在CY 216和CY 222的纳克浓度下观察到最大效应(降低30%)。它们的N-去硫酸化N-乙酰化对应物(CY 142和CY 143)而非肝素表现出类似的效应。每天皮下给仓鼠注射CY 216和CY 222,在治疗后1、2、4、7和24小时采集血液,以测定血清弹性蛋白酶活性(E.A.)和血清弹性蛋白酶抑制能力(E.I.C.)。注射CY 216或CY 222后2小时,E.A.水平下降30%,但在4 - 7小时后恢复到原始值。这种效应与治疗持续时间无关。用CY 216和CY 222治疗3 - 4周后,仓鼠血清E.I.C.显著增加(大于30%)。这些发现表明这些化合物在诸如肺气肿等与弹性蛋白酶相关疾病中的潜在用途。